The iron chelator deferasirox protects mice from mucormycosis through iron starvation

Mucormycosis causes mortality in at least 50% of cases despite current first-line therapies. Clinical and animal data indicate that the presence of elevated available serum iron predisposes the host to mucormycosis. Here we demonstrate that deferasirox, an iron chelator recently approved for use in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Ibrahim, Ashraf S., Gebermariam, Teclegiorgis, Fu, Yue, Lin,, Lin, Husseiny, Mohamed I., French, Samuel W., Schwartz, Julie, Skory, Christopher D., Edwards, John E., Spellberg, Brad J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2007
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1957543/
https://ncbi.nlm.nih.gov/pubmed/17786247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI32338
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados